XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 71 filers reported holding XENON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $216,000 | – | 16,500 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |